| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Ovid Therapeutics Inc. | Chief Operating Officer | Common Stock | 28.1K | $60.5K | $2.15 | Feb 22, 2024 | Direct |
| IMMUNIC, INC. | President and COO | Stock Option | 500K | Jul 12, 2024 | Direct | ||
| Ovid Therapeutics Inc. | Chief Operating Officer | Stock Option (Right to Buy) | 169K | Feb 22, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| IMUX | IMMUNIC, INC. | Jul 12, 2024 | 1 | $0 | 4 | Jul 12, 2024 | President and COO |
| IMUX | IMMUNIC, INC. | Jul 12, 2024 | 0 | $0 | 3 | Jul 12, 2024 | President and COO |
| OVID | Ovid Therapeutics Inc. | Feb 22, 2024 | 2 | $0 | 4 | Feb 26, 2024 | Chief Operating Officer |
| OVID | Ovid Therapeutics Inc. | Feb 23, 2023 | 1 | $0 | 4 | Feb 27, 2023 | Chief Operating Officer |
| OVID | Ovid Therapeutics Inc. | Sep 12, 2022 | 1 | -$37.3K | 4 | Sep 14, 2022 | Chief Operating Officer |
| OVID | Ovid Therapeutics Inc. | Apr 8, 2022 | 2 | $0 | 4 | Apr 12, 2022 | Chief Operating Officer |
| OVID | Ovid Therapeutics Inc. | Feb 3, 2022 | 1 | $0 | 4 | Feb 4, 2022 | Chief Operating Officer |
| OVID | Ovid Therapeutics Inc. | Jul 1, 2021 | 1 | $0 | 4 | Jul 1, 2021 | Chief Commercial Officer |